Company Analysis

Johnson & Johnson (JNJ)

NYSE: JNJ · Pharmaceutical Preparations · New Brunswick, NJ · filing with the SEC since 1994
Grade6.5
◀ Past 7.6● Present 7.0▶ Future 4.9

Income statement, as filed

In millions of US dollars (USD), as filed; per-share figures in US dollars; share counts in millions. The fiscal year ends in January.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period endingDec 28, 2025Dec 29, 2024Dec 31, 2023Jan 1, 2023Jan 2, 2022Jan 3, 2021Dec 29, 2019Dec 30, 2018Dec 31, 2017Jan 1, 2017
Report filedFeb 11, 2026Feb 13, 2025Feb 16, 2024Feb 16, 2023Feb 17, 2022Feb 22, 2021Feb 18, 2020Feb 20, 2019Feb 21, 2018Feb 27, 2017
Revenue94,19388,82185,15979,990r78,740r82,58482,05981,58176,45071,890
Cost of revenue30,25627,47126,55324,596r23,402r28,42727,55627,09125,43921,789r
Gross profit63,93761,35058,60655,394r55,338r54,15754,50354,49051,011r50,101r
Research and development14,66517,23215,08514,135r14,277r12,15911,35510,77510,594r9,143r
Selling, general and administrative23,67622,86921,51220,246r20,118r22,08422,17822,54021,520r20,067r
Interest expense9717557722761832013181,005934726
Interest and investment income1,0561,3321,26149053111357611385368
Other income (expense), net7,209-4,694-6,634-810r-526r-2,899-2,525-1,40542r-210r
Income before income taxes32,58116,68715,06219,359r19,178r16,49717,32817,99917,67319,803
Income tax expense5,7772,6211,7362,989r1,377r1,7832,2092,70216,3733,263
Income from continuing operations26,80414,06613,32616,37017,801·····
Income from discontinued operations0021,8271,5713,077·····
Net income26,80414,06635,15317,94120,87814,71415,11915,2971,30016,540
Earnings per share, basic11.135.8413.886.837.935.595.725.700.486.04
Earnings per share, diluted11.035.7913.726.737.815.515.635.610.475.93
Weighted average shares, basic2,407.42,407.32,533.52,625.22,632.12,632.82,645.12,681.52,692.02,737.3
Weighted average shares, diluted2,429.42,429.42,560.42,663.92,674.02,670.72,684.32,728.72,745.32,788.9
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:SalesRevenueGoodsNet
Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfGoodsAndServicesSold
us-gaap:CostOfGoodsSold
Gross profit revenue less the cost of what it soldus-gaap:GrossProfit
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
Selling, general and administrative the cost of selling and of running the companyus-gaap:SellingGeneralAndAdministrativeExpense
Interest expense what its borrowing costus-gaap:InterestExpenseNonoperating
us-gaap:InterestExpense
Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeInterest
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Income from continuing operations profit from the businesses it keepsus-gaap:IncomeLossFromContinuingOperations
Income from discontinued operations profit or loss from businesses it sold or closedus-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
SI Assistanton JNJ · research, not advice